Boosting therapeutic efficacy of mesenchymal stem cells in pulmonary fibrosis: The role of genetic modification and preconditioning strategies

Pulmonary fibrosis (PF) is the end stage of severe lung diseases, in which the lung parenchyma is replaced by fibrous scar tissue. The result is a remarkable reduction in pulmonary compliance, which may lead to respiratory failure and even death. Idiopathic pulmonary fibrosis (IPF) is the most preva...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehrabani, Mehrnaz, Mohammadyar, Sohaib, Rajizadeh, Mohammad Amin, Bejeshk, Mohammad Abbas, Ahmadi, Bahareh, Nematollahi, Mohammad Hadi, Mirtajaddini Goki, Maryamossadat, Bahrampour Juybari, Kobra, Amirkhosravi, Arian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440137/
https://www.ncbi.nlm.nih.gov/pubmed/37605719
http://dx.doi.org/10.22038/IJBMS.2023.69023.15049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440137/
https://www.ncbi.nlm.nih.gov/pubmed/37605719
http://dx.doi.org/10.22038/IJBMS.2023.69023.15049

Ejemplares similares